Key takeaway
A company with $16.956 billion of quarterly revenue, a $567 million GAAP operating loss and a $23.291 billion net loss has drawn roughly six times the demand for its shares. That tells you about demand, not about value — and the real information does not arrive until the pricing date.
1. The event: from pushback to scramble in ten days
Anthropic publicly filed its updated prospectus on October 26, 2026. On November 10 it opened its roadshow with a price range of $70 to $78 per share, seeking a listing on the Nasdaq Global Select Market under the ticker "ANT."
On November 11, reports said institutional orders on the first day of the roadshow already covered the entire offering, and that underwriters were considering pricing above the stated range. The Financial Times reported that banks were discussing a valuation above $1.5 trillion.
On November 13, Bloomberg reported that orders had reached roughly six times the shares available, and that underwriters had told prospective buyers the allocation would favor existing shareholders, leaving some buyers with less than they expected.
On November 16 — today in Beijing — several outlets citing people familiar with the matter put orders close to seven times the available stock.
The published schedule has pricing on November 18 and the first day of trading on November 19. Anthropic would become the first AI company to enter the public market at a trillion-dollar-scale valuation.
2. The core facts
| Item | Figure | Basis and source |
|---|---|---|
| Issuer | Anthropic, PBC | Prospectus |
| Listing venue / ticker | Nasdaq Global Select Market / ANT | Prospectus |
| Shares offered | 825 million Class A shares | Prospectus |
| Of which sold by the company | 801 million shares | Prospectus |
| Of which sold by existing holders | 23.6486 million shares | Proceeds go to selling holders, not the company |
| Price range | $70 to $78 per share | Prospectus |
| Gross proceeds to the company at the top of the range | About $62.478 billion | 801 million shares at $78 |
| Underwriters' option | Up to 124 million additional shares within 30 days | Prospectus |
| Oversubscription | About 6x (November 13) | Bloomberg, citing people familiar |
| Latest reading | Close to 7x (November 16) | Media citing people familiar, not company-confirmed |
| Pricing date / first trade | November 18 / November 19 | Published schedule |
| Valuation path | $2 trillion to $1.5 trillion to $1.0-1.4 trillion | Compiled from media reports |
| Q3 revenue | $16.956 billion, +1,127% year over year, roughly +47% sequentially | Prospectus |
| Q3 operating loss | $567 million (Q2 was a $974 million operating profit) | Prospectus |
| Q3 net loss | $23.291 billion | Includes about $21.9 billion of non-cash fair value losses |
| Nine-month revenue | $33.242 billion, +1,206.3% year over year | Prospectus |
| Q3 compute and infrastructure cost | $9.863 billion | Prospectus |
3. What six times oversubscription does and does not tell you
It tells you demand is real. By the third day of the roadshow, orders stood at roughly six times the shares on offer. That gives underwriters room to price at the top of the range, or above it, without worrying about clearing the book.
It does not tell you the valuation is reasonable. Oversubscription is a demand signal, not a value judgment. The 2020-2021 IPO market produced many deals with double-digit oversubscription multiples, and a fair number of them traded below their offer price within a year. There is no stable relationship between the subscription multiple and long-run returns.
It does not tell you that retail buyers will get shares. Bloomberg's reporting said plainly that underwriters would prioritize existing shareholders and that some buyers would receive less than they expected. The other side of heavy oversubscription is extreme concentration in allocation.
4. Why this pricing matters more than OpenAI's round
On November 14 we covered OpenAI raising $15 billion at a $1.25 trillion pre-money valuation. That was a private-market price with no public book-building and no comparable reference.
Anthropic is different: it will be priced daily in public markets. The $70 to $78 range maps to a defined valuation band, and once pricing is set on November 18 the secondary market will produce a new price every day. For the first time, the question "what is an AI company worth" gets a continuously observable answer.
For OpenAI this cuts both ways. If Anthropic prices at the top of the range or above and trades well on day one, the $1.25 trillion private mark gains support. If it breaks issue on the first day, the 2027 window gets re-examined.
5. The financial picture: very fast revenue growth, a net loss inflated by non-cash items
Per the prospectus, Anthropic reported $16.956 billion of third-quarter revenue, up 1,127% year over year and about 47% sequentially, with $33.242 billion for the first nine months, up 1,206.3%. At the operating line, Q3 showed a $567 million loss, a reversal from a $974 million operating profit in Q2.
The $23.291 billion net loss needs to be decomposed. About $21.9 billion comes from fair value losses on convertible notes, derivative liabilities and SAFEs — non-cash accounting items that grow as the valuation rises, not operating cash outflows. Strip that out and the operating-scale loss is in the hundreds of millions.
This matters when reading IPO financials: the higher the valuation, the larger those fair value losses, and the larger the net loss. Using net loss to judge operating quality turns a valuation increase into an apparent deterioration in operations.
6. Three things to watch on November 18
First, whether pricing lands inside or above $70 to $78. Pricing inside the range suggests underwriters want to leave secondary-market room; a raise suggests demand strong enough to give up first-day upside.
Second, the final proceeds and use of the overallotment option. Company proceeds are about $62.478 billion at the top of the range; exercising the full 124 million-share option adds more. The final number determines how long that capital can fund infrastructure buildout.
Third, how the first day of trading goes. A break of issue would immediately change the narrative across the AI complex; a strong debut would reinforce the "buy share with losses" logic. Neither is a judgment about long-run value, but both feed directly into the financing terms available to OpenAI and others still private.
7. Boundaries and inferences to avoid
- Share counts, price range, proceeds and the overallotment option come from the S-1/A filed with the U.S. Securities and Exchange Commission, a public document;
- The 6x and near-7x subscription figures come from media citing people familiar with the matter; the company has not confirmed them, and orders can be revised or withdrawn before pricing;
- The report that underwriters are discussing a valuation above $1.5 trillion comes from the Financial Times and remains unresolved;
- Revenue, operating loss and net loss are GAAP figures disclosed in the prospectus;
- The $23.291 billion net loss includes about $21.9 billion of non-cash fair value losses; it is neither cash burn nor operating loss;
- The valuation path is compiled from media reports with differing timing and definitions and should not be plotted as a single series;
- This article does not forecast the pricing outcome, does not judge whether the valuation is reasonable, and is not investment advice.
8. Sources
- Anthropic IPO prospectus (S-1/A, November 10, 2026): https://ipo.anthropic.com/documents/us/prospectus.pdf
- Caixin, "Anthropic IPO to raise up to $62.5 billion, valuation cut to $1.0-1.4 trillion" (November 11, 2026): https://www.caixin.com/2026-11-11/102503301.html
- Caixin, "Anthropic Q3 revenue surges, operating profit turns to loss" (November 3, 2026): https://www.caixin.com/2026-11-03/102500358.html
- Bloomberg report via Moneycontrol, "Anthropic's IPO is about six times oversubscribed, report says" (November 13, 2026): http://www.moneycontrol.com/news/business/ipo/anthropic-s-ipo-is-about-six-times-oversubscribed-report-says-14078609.html
- Related on this site: Anthropic vs OpenAI: IPO valuation and funding comparison
